Cargando…
NI-20 IS GLIOMATOSIS CEREBRI DIAGNOSED AS GRADEII IN NEUROIMAGING A POTENTIALLY GRADEII GLIOMA?
The 2007 World Health Organization (WHO) classification defined gliomatosis cerebri (GC) as a rare entity and an extensively infiltrating diffuse glioma involving three or more cerebral lobes. Although the revised 2016 WHO classification removed GC as a separate glioma entity due to the common histo...
Autores principales: | Owashi, Etsuko, Takei, Hiroaki, Ikegame, Yuka, Asano, Yoshitaka, Miwa, Kazuhiro, Ito, Takeshi, Yokoyama, Kazutoshi, Shinoda, Jun, Maruyama, Takashi, Muragaki, Yoshihiro, Yano, Hirohito, Iwama, Toru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213467/ http://dx.doi.org/10.1093/noajnl/vdz039.131 |
Ejemplares similares
-
NI-05 CLINICOPATHOLOGICAL ANALYSIS AND METHIONINE PET ANALYSIS IN PATIENTS WITH GLIOMATOSIS CEREBRI
por: Yano, Hirohito, et al.
Publicado: (2019) -
NI-01 CONTRAST-ENHANCED MRI AND POSITRON EMISSION TOMOGRAPHY FOR DISTINGUISHING THE GRADE OF GLIOMA
por: Takei, Hiroaki, et al.
Publicado: (2019) -
NI-6 Preoperative differential diagnosis of grade II and grade III in cases with astrocytoma, IDH mutant
por: Yano, Hirohito, et al.
Publicado: (2021) -
Differentiation of astrocytoma between grades II and III using a combination of methionine positron emission tomography and magnetic resonance spectroscopy
por: Yano, Hirohito, et al.
Publicado: (2023) -
Radiological Prediction of Isocitrate Dehydrogenase (IDH) Mutational Status and Pathological Verification for Lower-Grade Astrocytomas
por: Yano, Hirohito, et al.
Publicado: (2022)